GNH USA

Europe — EMA

Novantron (Mitoxantrone Hydrochloride)

GNH USA supplies Novantron (Mitoxantrone Hydrochloride), a anthracenedione antineoplastic for acute myeloid leukemia, metastatic prostate cancer, progressive

Mitoxantrone Hydrochloride

Request sourcing

1
Pack/s

What is Mitoxantrone Hydrochloride?

Mitoxantrone Hydrochloride, the active ingredient in Novantron, is an anthracenedione antineoplastic presented as an injection solution for intravenous, intraperitoneal, and intrapleural use. It is indicated for the treatment of acute myeloid leukemia, metastatic prostate cancer, progressive multiple sclerosis, and non‑Hodgkin lymphoma in adult patients. It is formulated for sterile administration and is marketed within the European Union.

GNH USA supplies Novantron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide. The company adheres to stringent quality standards and provides reliable logistics to support clinical programs.

What is Mitoxantrone Hydrochloride used for?

Novantron (mitoxantrone hydrochloride) is used in hematologic and solid‑tumor malignancies as well as certain autoimmune conditions.

Acute Myeloid Leukemia: improves remission rates in adult patients Metastatic Prostate Cancer: provides disease control in hormone‑refractory cases Progressive Multiple Sclerosis: reduces relapse frequency and disability progression Non‑Hodgkin Lymphoma: contributes to remission in relapsed or refractory disease

What are the side effects of Mitoxantrone Hydrochloride?

Novantron may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Fatigue - Alopecia - Myelosuppression (neutropenia, anemia, thrombocytopenia) - Mucositis - Transient elevation of liver enzymes

Serious or Rare Side Effects: - Cardiotoxicity (dose‑related decline in left ventricular ejection fraction) - Secondary acute myeloid leukemia - Severe infections due to neutropenia - Hemorrhage - Pulmonary toxicity - Severe hypersensitivity reactions

What precautions apply to Mitoxantrone Hydrochloride?

When using Novantron, several safety measures should be observed. - Cardiac Monitoring: baseline and periodic echocardiograms are recommended due to risk of cardiotoxicity. - Hematologic Surveillance: complete blood counts should be performed before each dose to detect myelosuppression. - Renal Function: assess creatinine clearance as impaired function may affect clearance. - Pregnancy Category D: avoid use in pregnancy unless benefits outweigh risks; advise effective contraception. - Drug Interactions: review concomitant medications for additive myelosuppressive or cardiotoxic potential. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Mitoxantrone Hydrochloride interact with?

Mitoxantrone interacts with several agents that can modify its efficacy or toxicity.

Major Interactions (Avoid): - Anthracyclines (e.g., doxorubicin): combined use markedly increases cardiotoxic risk. - Radiation therapy: concurrent administration may exacerbate bone‑marrow suppression. - Live vaccines: immunosuppression can lead to severe infection.

Moderate Interactions (Monitor Closely): - Cyclophosphamide and other alkylating agents: additive myelosuppression. - CYP450 inhibitors (e.g., ketoconazole): may increase plasma levels. - Anticoagulants (e.g., warfarin): heightened bleeding risk due to thrombocytopenia.

Frequently asked questions

What conditions is Novantron used to treat?+
Novantron, containing mitoxantrone hydrochloride, is indicated for adult patients with acute myeloid leukemia, metastatic prostate cancer, progressive multiple sclerosis, and non‑Hodgkin lymphoma. These indications reflect its activity against rapidly proliferating malignant cells and certain immune‑mediated disease processes.
How does mitoxantrone hydrochloride work?+
Mitoxantrone hydrochloride intercalates into DNA and stabilizes the topoisomerase II‑DNA complex, preventing the re‑ligation of DNA strands. This results in persistent double‑strand breaks, leading to apoptosis of rapidly dividing cells such as cancerous lymphocytes and myeloid precursors.
What determines the dosing regimen for Novantron?+
The dose and schedule of Novantron are individualized by the prescribing clinician based on the specific indication, disease severity, patient weight, renal and hepatic function, and prior treatment history. No fixed regimen is provided publicly; the prescriber sets the appropriate regimen.
Is Novantron safe during pregnancy or breastfeeding?+
Novantron is classified as Pregnancy Category D, indicating evidence of fetal risk. It should be avoided in pregnant women unless the potential therapeutic benefit justifies the risk. Breastfeeding is not recommended because the drug can be excreted in milk and may harm the infant.
How do I order Novantron from GNH USA?+
To order Novantron, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.
How does Novantron compare with other antineoplastic agents?+
Novantron belongs to the anthracenedione class, offering a distinct mechanism of DNA intercalation and topoisomerase II inhibition compared with alkylating agents or taxanes. Its efficacy in certain leukemias and solid tumours is comparable to other cytotoxics, but it carries a unique risk profile, especially for cardiotoxicity and secondary malignancies.
What are the recommended storage conditions for Novantron?+
Novantron should be stored at 2‑8 °C (refrigerated). Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the solution. If temporary storage at controlled room temperature is unavoidable, limit exposure to less than 24 hours.
How is Novantron administered to patients?+
Novantron is supplied as a sterile injection solution and is administered intravenously, intraperitoneally, or intrapleurally by a qualified healthcare professional. The infusion rate and volume are determined by the prescriber and nursing staff according to the treatment protocol and patient tolerance.
What are the most serious risks associated with Novantron?+
The most serious adverse events include dose‑related cardiotoxicity, secondary acute myeloid leukemia, severe myelosuppression leading to infections or bleeding, and rare pulmonary toxicity. Patients should be monitored closely with cardiac imaging, blood counts, and clinical assessment throughout therapy.
Who should not use Novantron?+
Novantron is contraindicated in patients with known hypersensitivity to mitoxantrone or any formulation component, in those with uncontrolled cardiac disease, and in pregnant women unless no alternative exists. Caution is also advised for individuals with severe hepatic or renal impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Mitoxantrone Hydrochloride
Route
Intraperitoneal Use , Intrapleural Use , Intraveno
Manufacturer
Viatris Healthcare Gmbh
Origin
EU

Related products

Ebexantron

Ebexantron

Mitoxantrone Hydrochloride

Ebewe Pharma
EU
Mitoxantron Sandoz

Mitoxantron Sandoz

Mitoxantrone Hydrochloride

Sandoz B.V.
EU
Mitoxantrone Baxter

Mitoxantrone Baxter

Mitoxantrone Hydrochloride

Baxter Médico-Farmacêutica, Lda.
EU
Novantrone

Novantrone

Mitoxantrone Hydrochloride

Viatris Medical
EU